A 32-year-old woman with a 6-month history of episodic nocturnal cough and dyspnea presents for evaluation of suspected asthma. Spirometry shows normal baseline FEV1 (88% predicted) with no bronchodilator reversibility (FEV1 increase 8%). A methacholine challenge test is performed. The patient develops a 20% drop in FEV1 at a methacholine concentration of 2.5 mg/mL, as marked by **C** in the diagram. Which of the following best describes the diagnostic significance of this finding?

Explanation

## Why PC20 < 4 mg/mL confirms bronchial hyperresponsiveness and supports asthma diagnosis when clinical suspicion is high and BD reversibility is negative is right The methacholine challenge test is a bronchial provocation test designed to detect bronchial hyperresponsiveness by measuring the provocative concentration (PC20) of methacholine that causes a 20% drop in FEV1. A PC20 < 4 mg/mL is the threshold for a POSITIVE test indicating significant airway hyperresponsiveness. In this patient with compatible clinical history (nocturnal cough, dyspnea), normal baseline FEV1, and negative bronchodilator reversibility, a positive methacholine challenge (PC20 < 4 mg/mL) provides critical diagnostic support for asthma. According to GINA 2024 and Harrison 21e, demonstrating variable expiratory airflow limitation via PC20 positivity is one of the four accepted methods to confirm asthma diagnosis when clinical suspicion is high. The test has high negative predictive value—a negative result essentially rules out asthma—making it particularly useful in this diagnostic scenario. ## Why each distractor is wrong - **PC20 < 4 mg/mL is highly specific for asthma and excludes all other causes of chronic cough**: This overstates specificity. While methacholine challenge has high negative predictive value, a positive result is NOT specific to asthma alone. Positive PC20 can occur in COPD, allergic rhinitis, smokers, and post-upper respiratory tract infection patients. The test confirms hyperresponsiveness but not asthma exclusively. - **PC20 < 4 mg/mL indicates the patient has exercise-induced bronchoconstriction and requires mannitol challenge for confirmation**: This confuses different provocation tests. Methacholine challenge detects general bronchial hyperresponsiveness, not specifically exercise-induced bronchoconstriction. Exercise challenge and mannitol are alternative provocation tests used for different clinical scenarios (EIB and portable testing, respectively), not confirmatory tests for methacholine positivity. - **PC20 < 4 mg/mL is diagnostic of COPD and rules out asthma in patients with normal baseline FEV1**: This is factually incorrect. A positive methacholine challenge in the context of normal baseline FEV1 and clinical history of episodic symptoms is consistent with asthma, not COPD. COPD typically presents with irreversible airflow obstruction and abnormal baseline FEV1. Methacholine positivity in COPD occurs but is a confounding finding, not diagnostic. **High-Yield:** PC20 < 4 mg/mL = positive methacholine challenge; high negative predictive value rules out asthma; positive result supports but does not confirm asthma diagnosis—must integrate with clinical history and exclude alternative causes. [cite: Harrison 21e Ch 286; GINA 2024]